Bridgeway Capital Management LLC Buys New Shares in Cardlytics, Inc. (NASDAQ:CDLX)

Bridgeway Capital Management LLC bought a new position in shares of Cardlytics, Inc. (NASDAQ:CDLXFree Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 112,000 shares of the company’s stock, valued at approximately $416,000. Bridgeway Capital Management LLC owned approximately 0.22% of Cardlytics at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Mirabella Financial Services LLP acquired a new position in shares of Cardlytics during the fourth quarter worth about $4,285,000. Rangeley Capital LLC purchased a new position in Cardlytics in the fourth quarter worth approximately $1,187,000. RBF Capital LLC grew its holdings in Cardlytics by 64.7% during the 4th quarter. RBF Capital LLC now owns 803,763 shares of the company’s stock worth $2,982,000 after acquiring an additional 315,635 shares in the last quarter. Natixis purchased a new stake in shares of Cardlytics in the 4th quarter valued at approximately $462,000. Finally, Susquehanna Fundamental Investments LLC acquired a new stake in shares of Cardlytics in the 4th quarter valued at $331,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on CDLX. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th. Lake Street Capital lowered their price objective on Cardlytics from $3.00 to $2.50 and set a “hold” rating for the company in a research report on Thursday, May 8th. Finally, Evercore ISI cut their target price on Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a research report on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $5.20.

View Our Latest Report on Cardlytics

Cardlytics Price Performance

Shares of CDLX opened at $2.17 on Tuesday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics, Inc. has a 1-year low of $1.22 and a 1-year high of $10.01. The stock has a market cap of $113.93 million, a PE ratio of -0.36 and a beta of 1.30. The firm has a fifty day moving average price of $1.81 and a 200 day moving average price of $2.95.

Insiders Place Their Bets

In related news, CEO Amit Gupta sold 46,857 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the transaction, the chief executive officer now owns 418,637 shares in the company, valued at $1,423,365.80. This trade represents a 10.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Alexis Desieno sold 24,778 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the completion of the sale, the chief financial officer now owns 140,948 shares of the company’s stock, valued at approximately $479,223.20. This represents a 14.95% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 71,938 shares of company stock valued at $244,017. 4.40% of the stock is currently owned by insiders.

About Cardlytics

(Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Further Reading

Institutional Ownership by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.